Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
4.230
+0.330 (8.46%)
At close: Mar 9, 2026, 4:00 PM EDT
4.250
+0.020 (0.47%)
After-hours: Mar 9, 2026, 7:58 PM EDT
Incannex Healthcare Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Market Capitalization | 51 | 20 | 47 | 2,912 | 4,943 | - | |
| Market Cap Growth | 76.27% | -56.69% | -98.40% | -41.09% | - | - | |
| Enterprise Value | -18 | 15 | 38 | 2,884 | 4,929 | - | |
| Last Close Price | 3.90 | 6.47 | 88.20 | 220.20 | 462.60 | - | |
| PS Ratio | - | 235.00 | 3888.91 | - | 9170.51 | - | |
| PB Ratio | 0.64 | 1.51 | 4.16 | 139.84 | 200.03 | - | |
| P/TBV Ratio | 0.69 | 1.51 | 4.16 | 139.84 | 200.03 | - | |
| EV/Sales Ratio | - | 176.58 | 3147.58 | - | 9143.84 | - | |
| Debt / Equity Ratio | 0.00 | 0.02 | 0.03 | 0.03 | - | - | |
| Net Debt / Equity Ratio | -0.94 | -1.10 | -0.49 | -1.04 | -1.04 | -1.06 | |
| Net Debt / EBITDA Ratio | 2.71 | 0.68 | 0.30 | 1.59 | - | - | |
| Net Debt / FCF Ratio | 3.73 | 1.18 | 0.34 | 1.95 | 2.93 | 1.32 | |
| Asset Turnover | - | 0.01 | 0.00 | - | 0.03 | 0.28 | |
| Quick Ratio | 47.96 | 2.82 | 2.82 | 8.75 | 18.80 | 12.31 | |
| Current Ratio | 48.27 | 2.86 | 2.88 | 9.02 | 18.84 | 12.36 | |
| Return on Equity (ROE) | -130.43% | -381.09% | -115.22% | -218.40% | -67.07% | -193.77% | |
| Return on Assets (ROA) | -36.96% | -73.45% | -56.96% | -34.80% | -30.05% | -93.86% | |
| Return on Capital Employed (ROCE) | -34.70% | -163.70% | -162.80% | -64.20% | -31.60% | -118.80% | |
| Earnings Yield | -95.99% | -231.99% | -39.55% | -1.68% | -0.21% | - | |
| FCF Yield | -36.48% | -61.95% | -34.55% | -0.38% | -0.18% | - | |
| Buyback Yield / Dilution | -1020.94% | -113.15% | -5.07% | 94.83% | -21.93% | -42.82% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.